Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

StemSight: curing blindness with stem cells

Project description

Stem cell-based treatment of corneal blindness

Differentiation of corneal limbal stem cells (LSCs) from human pluripotent stem cells (hPSCs) represents a promising treatment for ocular surface reconstruction and corneal epithelial renewal in cases of corneal blindness. However, a lack of understanding regarding the true LSC population identity and homeostasis regulation prevents the development of therapies based on hPSC-derived LSCs. StemSight, based in Finland, is developing off-the-shelf stem cell therapies to cure blindness. The company aims to develop strategies to solve the global shortage of corneal donor tissue by producing tissue products using induced pluripotent stem cells and biomaterials. The goal of the EU-funded SightLeaders project is the identification of the specific markers and maintenance of the clinically relevant LSC population.

Objective

StemSight is developing off-the-shelf stem cell therapies to cure blindness. We aim to solve the global shortage of corneal donor tissue by producing high-quality tissue products using allogeneic induced pluripotent stem cells (iPSCs) and biomaterials. Our lead product is aimed at a rare but severe form of corneal blindness, limbal stem cell deficiency (LSCD), for which there are currently no valid treatment options. The company's innovations have arisen from extensive academic research, and the company has spun out from Tampere University, Finland in 2021. StemSight is a rare kind of deep-tech startup, as all of its scientific founders are women.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIE-2022-SCALEUP-02

See all projects funded under this call

Coordinator

STEMSIGHT OY
Net EU contribution
€ 75 000,00
Address
BIOKATU 12
33520 Tampere
Finland
SME
Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data